Colorectal cancer Clinical Trials in Washington D.C., DC
As of October 2026, 10 paid clinical trials are recruiting for Colorectal cancer in Washington D.C., District of Columbia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Washington D.C.
Filter results
10 clinical trials for Colorectal cancer
·Clear filters·FOG-001 in Locally Advanced or Metastatic Solid Tumors
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Colorectal Cancer Screening in the Homeless
Top Research Study Locations in Washington D.C.
Researchers run research studies in Washington D.C., DC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MedStar Washington Hospital Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 95 |
| Children's National Hospital | Sickle Cell Disease, Medulloblastoma Recurrent, Asthma in Children | 89 |
| Children's National Medical Center | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Neuroblastoma | 84 |
| MedStar Georgetown University Hospital | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Advanced Esophageal Adenocarcinoma | 70 |
| Sibley Memorial Hospital | Bladder Cancer, Breast Cancer, Brain Tumor | 43 |
| Georgetown University | Alzheimer Disease, Amyotrophic Lateral Sclerosis, HIV | 38 |
| Georgetown University Medical Center | Breast Cancer, Locally Advanced Solid Tumor, Metastatic Solid Tumor | 33 |
| George Washington University | HIV Infection, Adult, Advanced Solid Tumor | 21 |
| George Washington University Medical Center | Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma | 15 |
| Children's National Health System | Anesthesia, Atopy, Autoimmunity | 11 |
| Georgetown Lombardi Comprehensive Cancer Center | Solid Tumor, Acute Myeloid Leukemia (AML) in Remission, Cancer Related Cognitive Decline | 10 |
| Kaiser Permanente-Capitol Hill Medical Center | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Breast Cancer | 10 |
| Washington Hospital Center | AIDS, Acute or Chronic Coronary Artery Disease, Aortic Valve Disease | 9 |
| MedStar Health Research Institute | Cancer, Cancer Pain, Central Line Associated Blood Stream Infections (CLABSI) | 9 |
| Childrens National Medical Center | Chronic Graft-versus-host-disease, Genetic Disease, Lymphatic Malformations | 7 |
| Georgetown University Hospital | Congenital Antithrombin Deficiency, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 7 |
| Washington DC VA Medical Center, Washington, DC | Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD), BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | 7 |
| MedStar National Rehabilitation Hospital | Lower Urinary Tract Disorder, Multiple Sclerosis, Neurogenic Bladder | 7 |
| GSK Investigational Site | HIV Infections, Gastrointestinal Neoplasms, Multiple Myeloma | 6 |
| Childrens National Hospital | Chronic Graft-versus-host-disease, Ewing Sarcoma, Familial Hypercholesterolemia - Heterozygous | 5 |
| Clinical Trial Site | AQP4+ NMOSD, Atypical Hemolytic-Uremic Syndrome, Generalized Myasthenia Gravis | 5 |
| George Washington University Hospital | Abdominal Compartment Syndrome, Acute Kidney Injury, Atrial Fibrillation | 5 |
| MedStar Health | Acute DVT of Lower Extremity, Acute Limb Ischemia, Arterial Embolism and Thrombosis | 5 |
| The George Washington University | Gestational Diabetes Mellitus in Pregnancy, Glucose Intolerance During Pregnancy, Metastatic Head-and-neck Squamous-cell Carcinoma | 5 |
| George Washington University Medical Faculty Associates | Controlled Human Infection, Cutaneous Squamous Cell Carcinoma (CSCC), Focal Segmental Glomerulosclerosis | 4 |
Active & Upcoming Studies in Washington D.C. (2026)
Recruiting trials in Washington D.C. grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (287 active studies)
- RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) · Phase 2 · Georgetown University
- Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features · Phase 2 · Georgetown University
Neurology & pain (61 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD · EARLY_Phase 1 · Medstar Health Research Institute
Cardiovascular (46 active studies)
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
- CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA) · VA Office of Research and Development
Diabetes & metabolic (24 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
HIV / STI (21 active studies)
- Decision Support Tool to Integrate PrEP Into Emergency Departments · Phase 1 · George Washington University
- Combatting HIV Or Other STIs Early (CHOOSE) · Westat
Pediatric (17 active studies)
- Optimizing Pain Treatment in Children On Mechanical Ventilation · Phase 3 · Weill Medical College of Cornell University
- Pediatric Radiation Therapy Registry · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mental health & behavior (16 active studies)
- ChatGPT-Supported Text Messaging Program for Smoking Cessation · George Washington University
- Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease · Dartmouth-Hitchcock Medical Center
Vaccines (9 active studies)
- Flu COVID Vaccine Views · George Washington University
- A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults · Phase 3 · Pfizer
Eye & vision (1 active study)
- The Myelin Disorders Biorepository Project · Children's Hospital of Philadelphia
Common conditions studied in Washington D.C.
- Breast Cancer (12 active studies)
- Sickle Cell Disease (12 active studies)
- Stroke (11 active studies)
- Solid Tumor (10 active studies)
- Diffuse Intrinsic Pontine Glioma (9 active studies)
- Heart Failure (9 active studies)
Leading research sponsors in Washington D.C.
- Children's National Research Institute
- Georgetown University
- National Cancer Institute (NCI)
- George Washington University
- Medstar Health Research Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Washington D.C.?
There are approximately 834 recruiting clinical trials in Washington D.C., District of Columbia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Washington D.C. pay participants?
Most recruiting trials in Washington D.C. compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Washington D.C.?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Washington D.C.?
The most common conditions under active study in Washington D.C. include Breast Cancer (12), Sickle Cell Disease (12), Stroke (11), Solid Tumor (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Washington D.C.?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Washington D.C. on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Washington D.C.?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Washington D.C.?
Recruiting research sites in Washington D.C. include MedStar Washington Hospital Center, Children's National Hospital, Children's National Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Washington D.C. right now?
The largest active categories in Washington D.C. are Cancer & tumors (287), Neurology & pain (61), Cardiovascular (46). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.